✦ LIBER ✦

Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts

✍ Scribed by David R. Stover; Jennifer Caldwell; Jarrod Marto; Karen Root; Juergan Mestan; Michael Stumm; Olga Ornatsky; Chris Orsi; Nina Radosevic; Linda Liao; Doriano Fabbro; Michael F. Moran

Book ID: 111636979
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 637 KB
Volume: 1
Category: Article
ISSN: 1542-6416
DOI: 10.1385/cp:1:1:069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential effects of choline kinase i

Differential effects of choline kinase inhibitors in tumoral and primary human cells

✍ A. Rodriguez-González; F. Fernández; J. Campos; A. Espinosa; J.C. Lacal 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Dose scheduling of the dual VEGFR and EG

Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima®) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts

✍ Daniel L. Gustafson; Barbara Frederick; Andrea L. Merz; David Raben 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 481 KB

69 POSTER Evaluating the duel kinase inh

69 POSTER Evaluating the duel kinase inhibitor lapatinib: Bioanalytical method development and pharmacokinetic analysis in mouse, rat, and human and determination of in vivo efficacy in a panel of EGFR wildtype and mutant human tumor xenograft models

✍ J. Cooper; F.E. Nieves; J. Kuhn; C.H. Takimoto; A.W. Tolcher; M.J. Wick 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A novel tumor targeting telomerase inhib

A novel tumor targeting telomerase inhibitor depletes cellular atp and inhibits human prostate tumor xenograft growth in nude mouse and enhances the radiosensitivity of cultured human prostate and brain tumor cells

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Differential sensitivities of trastuzuma

Differential sensitivities of trastuzumab (Herceptin®)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors

✍ Carmel T. Chan; Marianne Z. Metz; Susan E. Kane 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 580 KB

72 POSTER Preclinical evaluation of the

72 POSTER Preclinical evaluation of the tyrosine kinase inhibitor erlotinib: Bioanalytical method development and pharmacokinetic analysis and in vivo evaluation and comparison in a panel of human EGFR wildtype and mutant tumor xenograft models

✍ F.E. Nieves; J. Cooper; G.L. Mangold; J. Kuhn; C.H. Takimoto; A.W. Tolcher; M.J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB